Oncotice, 1 vial (BCG) by Organon.
Indications: Treatment and prophylaxis of carcinoma in situ of the urinary bladder and prevention of recurrence of non-muscle-invasive papillary tumours.
Administration: Intravesical instillation by a urologist, weekly induction then maintenance.
Storage: Store in a refrigerator at 2–8 °C. Do not freeze. Keep in the outer carton to protect from light.
Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only.
| Manufacturer | Organon / MSD |
| Active ingredient | BCG (Bacillus Calmette-Guérin), TICE strain, 2–8 × 10⁸ CFU — live attenuated mycobacteria. |
| Strength & pack | 1 vial of powder. |
| Form | Powder for intravesical suspension |
| Storage | Store in a refrigerator at 2–8 °C. Do not freeze. Keep in the outer carton to protect from light. |
| Regulatory status | Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only. |